.jpg)
Datavault AI Inc., a leader in AI-driven data visualization, valuation, and monetization, has announced a $150 million strategic investment from Scilex Holding Company. The investment, structured in two tranches—$8.067M closing on September 26, 2025, and $141.933M pending stockholder approval—will be executed in Bitcoin (BTC) at the Coinbase.com spot exchange rate. This capital aims to strengthen Datavault AI’s balance sheet, accelerate its supercomputing infrastructure, expand independent data exchanges, and unlock new revenue streams in biotech, energy, and entertainment markets.
Henry Ji, Ph.D., CEO and President of Scilex Holding Company, emphasized the alignment, stating, “Datavault AI’s cutting-edge technologies align perfectly with the biotech sector’s need for advanced data analytics, AI-driven insights, and super computing power. This investment reflects our belief in Datavault’s ability to transform markets where trust and precision are critical.”
Datavault AI’s CEO, Nathaniel Bradley, highlighted the significance for biotech, noting, “We believe the investment is particularly significant for biotech, strengthening the company’s high-performance computing capabilities and supporting partnerships with the U.S. Department of Energy’s Brookhaven National Laboratory and IBM WatsonX.” The investment will fuel platforms like the International Elements Exchange, International NIL Exchange, and American Politics Exchange, leveraging Web 3.0 and blockchain-secured data trading.
The biotech data monetization market, projected to reach $30-50 billion by 2024, and the life sciences analytics market, valued at $35.69 billion in 2024 with an 11.4% CAGR through 2030, present significant opportunities. Datavault AI’s patented platform, with 72 issued or pending patents, is positioned to capture value across biotech, energy, and entertainment by addressing trust, data integrity, and monetization challenges.
The investment includes an initial $8.067M tranche closing on September 26, 2025, and a $141.933M second tranche pending shareholder approval due to Nasdaq’s 19.99% ownership limit. Scilex will receive 278,914,094 DVLT shares at $0.5378 per share, with 15M shares issued initially and the remainder via a pre-funded warrant. Scilex gains rights to nominate two board directors if it holds at least 10% of DVLT’s stock, or one director if holding 5-10%.
Datavault AI’s stock (DVLT) surged to $1.164 on September 26, 2025, a 39.4% increase from $0.8348 the previous day, with a market cap of $75.86M (see finance card above). Scilex (SCLX) stock is at $28.705, slightly down from $28.87, with a market cap of $200.81M. The stock’s year-to-date performance shows volatility, with DVLT rising from $0.357 in August to $1.164 in September, while SCLX climbed from $17.76 to $28.705 over the same period.
The securities are offered under a Form S-3 registration statement (File No. 333-288538), filed with the SEC on July 7, 2025, and declared effective on July 9, 2025. A prospectus supplement will be filed with the SEC, available at http://www.sec.gov. The agreement restricts Datavault from issuing additional shares for 45 days post-initial closing and prohibits variable rate transactions until the second tranche closes. Scilex also has rights to participate in up to 20% of future financings before the second tranche closes.
Datavault AI (Nasdaq: DVLT) leads in AI-driven data experiences, valuation, and monetization. Its cloud-based platform offers solutions through its Acoustic Science and Data Science Divisions, including WiSA®, ADIO®, and Sumerian® technologies. With 72 patents, it serves industries like biotech, energy, and entertainment, focusing on blockchain-secured data trading and AI analytics.
Scilex (Nasdaq: SCLX) is an innovative revenue-generating company focused on non-opioid pain management, neurodegenerative, and cardiometabolic disease treatments. It targets high-unmet-need indications with non-opioid therapies to improve patient outcomes.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.